SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 125.88 |
| Enterprise Value ($M) | 65.89 |
| Book Value ($M) | 228.10 |
| Book Value / Share | 4.42 |
| Price / Book | 0.55 |
| NCAV ($M) | -57.27 |
| NCAV / Share | -1.11 |
| Price / NCAV | -2.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.20 |
| Return on Assets (ROA) | -0.17 |
| Return on Equity (ROE) | -0.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.95 |
| Current Ratio | 4.95 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 218.48 |
| Assets | 503.85 |
| Liabilities | 275.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Morgan Stanley | 5.50 | -40.76 | |
| 13G/A | Citadel Advisors Llc | 0.30 | ||
| 13G/A | Baker Bros. Advisors Lp | 4.99 | ||
| 13G/A | Vanguard Group Inc | 7.87 | 65.78 | |
| 13G | Goldman Sachs Group Inc | 8.80 | ||
| 13G/A | Millennium Management Llc | 4.70 | ||
| 13G/A | BlackRock, Inc. | 7.70 | 30.10 | |
| 13G/A | State Street Corp | 1.93 | -8.56 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 54,969 | 288,640 | 19.04 | |
| 41,625 | 173,785 | 23.95 | |
| 33,160 | 112,571 | 29.46 | |
| 45,308 | 157,116 | 28.84 | |
| 80,926 | 382,798 | 21.14 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TNYA – Tenaya Therapeutics, Inc. | TRML – Tourmaline Bio, Inc. |
| TSHA – Taysha Gene Therapies, Inc. | TWST – Twist Bioscience Corporation |
| TXMD – TherapeuticsMD, Inc. |
Financial data and stock pages provided by
Fintel.io